Development and validation of a race-agnostic computable phenotype for kidney health in adult hospitalized patients

Standard race adjustments for estimating glomerular filtration rate (GFR) and reference creatinine can yield a lower acute kidney injury (AKI) and chronic kidney disease (CKD) prevalence among African American patients than non–race adjusted estimates. We developed two race-agnostic computable pheno...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 19; no. 4; p. e0299332
Main Authors Ozrazgat-Baslanti, Tezcan, Ren, Yuanfang, Adiyeke, Esra, Islam, Rubab, Hashemighouchani, Haleh, Ruppert, Matthew, Miao, Shunshun, Loftus, Tyler, Johnson-Mann, Crystal, Madushani, R. W. M. A., Shenkman, Elizabeth A., Hogan, William, Segal, Mark S., Lipori, Gloria, Bihorac, Azra, Hobson, Charles
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 23.04.2024
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Standard race adjustments for estimating glomerular filtration rate (GFR) and reference creatinine can yield a lower acute kidney injury (AKI) and chronic kidney disease (CKD) prevalence among African American patients than non–race adjusted estimates. We developed two race-agnostic computable phenotypes that assess kidney health among 139,152 subjects admitted to the University of Florida Health between 1/2012–8/2019 by removing the race modifier from the estimated GFR and estimated creatinine formula used by the race-adjusted algorithm ( race-agnostic algorithm 1) and by utilizing 2021 CKD-EPI refit without race formula ( race-agnostic algorithm 2 ) for calculations of the estimated GFR and estimated creatinine. We compared results using these algorithms to the race-adjusted algorithm in African American patients. Using clinical adjudication, we validated race-agnostic computable phenotypes developed for preadmission CKD and AKI presence on 300 cases. Race adjustment reclassified 2,113 (8%) to no CKD and 7,901 (29%) to a less severe CKD stage compared to race-agnostic algorithm 1 and reclassified 1,208 (5%) to no CKD and 4,606 (18%) to a less severe CKD stage compared to race-agnostic algorithm 2. Of 12,451 AKI encounters based on race-agnostic algorithm 1, race adjustment reclassified 591 to No AKI and 305 to a less severe AKI stage. Of 12,251 AKI encounters based on race-agnostic algorithm 2, race adjustment reclassified 382 to No AKI and 196 (1.6%) to a less severe AKI stage. The phenotyping algorithm based on refit without race formula performed well in identifying patients with CKD and AKI with a sensitivity of 100% (95% confidence interval [CI] 97%–100%) and 99% (95% CI 97%–100%) and a specificity of 88% (95% CI 82%–93%) and 98% (95% CI 93%–100%), respectively. Race-agnostic algorithms identified substantial proportions of additional patients with CKD and AKI compared to race-adjusted algorithm in African American patients. The phenotyping algorithm is promising in identifying patients with kidney disease and improving clinical decision-making.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Competing Interests: The authors have declared that no competing interests exist.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0299332